Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma

Liang Shun Wang, Kuan Chih Chow, Yung Chang Lien, Kuang Tai Kuo, Wing Yin Li

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objectives: Tumor recurrence and metastasis are major causes of treatment failure in esophageal squamous cell carcinoma (ESCC). Recently, nm23, originally considered to be an anti-metastatic gene, has been reported to associate with various roles in different human cancers. We therefore investigated the clinical significance of nm23-H1 expression in ESCC. Methods: Pathological sections were immunohistochemically stained with monoclonal antibody that was specific to nm23-H1. Expression of positive nm23-H1 staining was further confirmed by Western blot and reverse transcription-polymerase chain reaction (RT-PCR). The relationship between nm23-H1 expression and clinicopathological variables was examined by statistical analysis. Except for 11 (7%) surgical morality, the remaining 145 patients entered the prognostic analysis. The cisplatin-based chemotherapy was established for the patients with tumor stages at or beyond IIb, or with tumor recurrence. Survival difference between groups was compared by log rank test. Results: Immunohistochemically, nm23-H1 expression was detected in 39.3% (57/145) of the pathological sections. It was positively correlated with tumor stage (P=0.002), evident lymphovascular invasion (P

Original languageEnglish
Pages (from-to)419-424
Number of pages6
JournalEuropean Journal of Cardio-thoracic Surgery
Volume26
Issue number2
DOIs
Publication statusPublished - Aug 2004
Externally publishedYes

Fingerprint

Neoplasms
Far-Western Blotting
Recurrence
Treatment Failure
Cisplatin
Reverse Transcription
Monoclonal Antibodies
Esophageal Squamous Cell Carcinoma
Staining and Labeling
Neoplasm Metastasis
Drug Therapy
Polymerase Chain Reaction
Survival
Genes

Keywords

  • Chemosensitivity
  • Esophageal carcinoma
  • nm23

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma. / Wang, Liang Shun; Chow, Kuan Chih; Lien, Yung Chang; Kuo, Kuang Tai; Li, Wing Yin.

In: European Journal of Cardio-thoracic Surgery, Vol. 26, No. 2, 08.2004, p. 419-424.

Research output: Contribution to journalArticle

Wang, Liang Shun ; Chow, Kuan Chih ; Lien, Yung Chang ; Kuo, Kuang Tai ; Li, Wing Yin. / Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma. In: European Journal of Cardio-thoracic Surgery. 2004 ; Vol. 26, No. 2. pp. 419-424.
@article{d37dfcce65fc47dda49c47b0c40b9f4a,
title = "Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma",
abstract = "Objectives: Tumor recurrence and metastasis are major causes of treatment failure in esophageal squamous cell carcinoma (ESCC). Recently, nm23, originally considered to be an anti-metastatic gene, has been reported to associate with various roles in different human cancers. We therefore investigated the clinical significance of nm23-H1 expression in ESCC. Methods: Pathological sections were immunohistochemically stained with monoclonal antibody that was specific to nm23-H1. Expression of positive nm23-H1 staining was further confirmed by Western blot and reverse transcription-polymerase chain reaction (RT-PCR). The relationship between nm23-H1 expression and clinicopathological variables was examined by statistical analysis. Except for 11 (7{\%}) surgical morality, the remaining 145 patients entered the prognostic analysis. The cisplatin-based chemotherapy was established for the patients with tumor stages at or beyond IIb, or with tumor recurrence. Survival difference between groups was compared by log rank test. Results: Immunohistochemically, nm23-H1 expression was detected in 39.3{\%} (57/145) of the pathological sections. It was positively correlated with tumor stage (P=0.002), evident lymphovascular invasion (P",
keywords = "Chemosensitivity, Esophageal carcinoma, nm23",
author = "Wang, {Liang Shun} and Chow, {Kuan Chih} and Lien, {Yung Chang} and Kuo, {Kuang Tai} and Li, {Wing Yin}",
year = "2004",
month = "8",
doi = "10.1016/j.ejcts.2004.03.045",
language = "English",
volume = "26",
pages = "419--424",
journal = "European Journal of Cardio-thoracic Surgery",
issn = "1010-7940",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma

AU - Wang, Liang Shun

AU - Chow, Kuan Chih

AU - Lien, Yung Chang

AU - Kuo, Kuang Tai

AU - Li, Wing Yin

PY - 2004/8

Y1 - 2004/8

N2 - Objectives: Tumor recurrence and metastasis are major causes of treatment failure in esophageal squamous cell carcinoma (ESCC). Recently, nm23, originally considered to be an anti-metastatic gene, has been reported to associate with various roles in different human cancers. We therefore investigated the clinical significance of nm23-H1 expression in ESCC. Methods: Pathological sections were immunohistochemically stained with monoclonal antibody that was specific to nm23-H1. Expression of positive nm23-H1 staining was further confirmed by Western blot and reverse transcription-polymerase chain reaction (RT-PCR). The relationship between nm23-H1 expression and clinicopathological variables was examined by statistical analysis. Except for 11 (7%) surgical morality, the remaining 145 patients entered the prognostic analysis. The cisplatin-based chemotherapy was established for the patients with tumor stages at or beyond IIb, or with tumor recurrence. Survival difference between groups was compared by log rank test. Results: Immunohistochemically, nm23-H1 expression was detected in 39.3% (57/145) of the pathological sections. It was positively correlated with tumor stage (P=0.002), evident lymphovascular invasion (P

AB - Objectives: Tumor recurrence and metastasis are major causes of treatment failure in esophageal squamous cell carcinoma (ESCC). Recently, nm23, originally considered to be an anti-metastatic gene, has been reported to associate with various roles in different human cancers. We therefore investigated the clinical significance of nm23-H1 expression in ESCC. Methods: Pathological sections were immunohistochemically stained with monoclonal antibody that was specific to nm23-H1. Expression of positive nm23-H1 staining was further confirmed by Western blot and reverse transcription-polymerase chain reaction (RT-PCR). The relationship between nm23-H1 expression and clinicopathological variables was examined by statistical analysis. Except for 11 (7%) surgical morality, the remaining 145 patients entered the prognostic analysis. The cisplatin-based chemotherapy was established for the patients with tumor stages at or beyond IIb, or with tumor recurrence. Survival difference between groups was compared by log rank test. Results: Immunohistochemically, nm23-H1 expression was detected in 39.3% (57/145) of the pathological sections. It was positively correlated with tumor stage (P=0.002), evident lymphovascular invasion (P

KW - Chemosensitivity

KW - Esophageal carcinoma

KW - nm23

UR - http://www.scopus.com/inward/record.url?scp=3543090912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543090912&partnerID=8YFLogxK

U2 - 10.1016/j.ejcts.2004.03.045

DO - 10.1016/j.ejcts.2004.03.045

M3 - Article

VL - 26

SP - 419

EP - 424

JO - European Journal of Cardio-thoracic Surgery

JF - European Journal of Cardio-thoracic Surgery

SN - 1010-7940

IS - 2

ER -